hydroxychloroquine has been researched along with Edema in 9 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Edema: Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Current Condition: He started 8 days after ingestion of hydroxychloroquine for probable SARS-COV-2 infection, with headache, facial and neck edema, desquamative dermatosis on trunk and upper extremities, went to private clinic with torpid evolution sent to third level for increased facial and neck edema, which merited orotracheal intubation, management with intravenous steroids and antihistamines." | 4.31 | [Caso clínico: síndrome de DRESS por hidroxicloroquina]. ( Armenta-Morales, J; Caballero-López, C; López-García, A; Pacheco-Jiménez, Y; Papaqui-Tapia, J; Ríos-López, J; Rivero-Yeverino, D, 2023) |
| "Disabling pansclerotic morphea of childhood (DPMC) is a rare subtype of juvenile localized scleroderma (JLS) characterized by pansclerosis mainly affecting children under the age of 14." | 2.61 | Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review. ( Cox, A; Heaton, V; Munro, J; Renton, WD; Samuel, C; Soh, HJ, 2019) |
| "She also had developed anasarca two years prior to presentation." | 1.39 | Systemic lupus erythematosus and granulomatous lymphadenopathy. ( Dhakal, AK; Shah, SC; Shakya, A; Shakya, H; Shiva, RK; Shrestha, D, 2013) |
| "Treatment with hydroxychloroquine again produced an excellent response." | 1.27 | Discoid lupus erythematosus involving the eyelids. ( Buntin, DM; Donzis, PB; Gately, LE; Insler, MS, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Pacheco-Jiménez, Y | 1 |
| Ríos-López, J | 1 |
| Caballero-López, C | 1 |
| López-García, A | 1 |
| Rivero-Yeverino, D | 1 |
| Papaqui-Tapia, J | 1 |
| Armenta-Morales, J | 1 |
| Darjani, A | 1 |
| Rafiei, R | 1 |
| Mesbah, A | 1 |
| Golmohammadi, R | 1 |
| Rafiee, B | 1 |
| Movaseghi, M | 1 |
| Soh, HJ | 1 |
| Samuel, C | 1 |
| Heaton, V | 1 |
| Renton, WD | 1 |
| Cox, A | 1 |
| Munro, J | 1 |
| Torregrosa Calatayud, JL | 1 |
| Garcías Ladaria, J | 1 |
| Sánchez Carazo, JL | 1 |
| Alegre de Miquel, V | 1 |
| Shrestha, D | 1 |
| Dhakal, AK | 1 |
| Shiva, RK | 1 |
| Shakya, A | 1 |
| Shah, SC | 1 |
| Shakya, H | 1 |
| Yang, DH | 1 |
| Chang, DM | 1 |
| Lai, JH | 1 |
| Huang, GS | 1 |
| Chang, WC | 1 |
| Hou, TY | 1 |
| Abbasi, S | 1 |
| Tarter, L | 1 |
| Farzaneh-Far, R | 1 |
| Farzaneh-Far, A | 1 |
| Donzis, PB | 1 |
| Insler, MS | 1 |
| Buntin, DM | 1 |
| Gately, LE | 1 |
| Bailey, DM | 1 |
1 review available for hydroxychloroquine and Edema
| Article | Year |
|---|---|
Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.
Topics: Antirheumatic Agents; Biological Products; Biopsy; Child, Preschool; Contracture; Edema; Hematopoiet | 2019 |
8 other studies available for hydroxychloroquine and Edema
| Article | Year |
|---|---|
[Caso clínico: síndrome de DRESS por hidroxicloroquina].
Topics: Adult; Drug Hypersensitivity Syndrome; Edema; Eosinophilia; Humans; Hydroxychloroquine; Male; Steroi | 2023 |
Discoid Lupus Erythematosus Presenting as Upper Eyelid Edema and Erythema.
Topics: Adult; Alopecia; Edema; Erythema; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; | 2017 |
[Melkersson-Rosenthal syndrome].
Topics: Aged; Biopsy; Doxycycline; Drug Therapy, Combination; Edema; Female; Humans; Hydroxychloroquine; Leu | 2013 |
Systemic lupus erythematosus and granulomatous lymphadenopathy.
Topics: Antibodies, Antinuclear; Child; Connective Tissue Diseases; Diagnosis, Differential; Disease Progres | 2013 |
Remitting seronegative symmetrical synovitis with pitting edema following acute intracranial hemorrhage.
Topics: Aged, 80 and over; Antirheumatic Agents; Edema; Glucocorticoids; Humans; Hydroxychloroquine; Intracr | 2011 |
Hydroxychloroquine: a treatable cause of cardiomyopathy.
Topics: Antirheumatic Agents; Biopsy; Cardiomyopathies; Coronary Angiography; Diagnosis, Differential; Dyspn | 2012 |
Discoid lupus erythematosus involving the eyelids.
Topics: Adult; Edema; Eyelid Diseases; Female; Fluorescent Antibody Technique; Humans; Hydroxychloroquine; I | 1984 |
Quinoline antimalarials. Folded chloroquine.
Topics: Animals; Antimalarials; Carrageenan; Chloroquine; Edema; Hydroxychloroquine; Mice; Piperidines; Quin | 1969 |